Page last updated: 2024-08-23

staurosporine and Lymphoma, Mantle-Cell

staurosporine has been researched along with Lymphoma, Mantle-Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Howard, OM; Kim, HH; Lin, TS; Neuberg, DS; Shipp, MA1
Bellosillo, B; Bosch, F; Campo, E; Colomer, D; Espinet, B; Ferrer, A; López-Guillermo, A; Marcé, S; Montserrat, E; Solé, F; Villamor, N1

Other Studies

2 other study(ies) available for staurosporine and Lymphoma, Mantle-Cell

ArticleYear
Seventy-two hour continuous infusion flavopiridol in relapsed and refractory mantle cell lymphoma.
    Leukemia & lymphoma, 2002, Volume: 43, Issue:4

    Topics: Aged; Alkaloids; Antineoplastic Agents; Female; Flavonoids; Humans; Infusions, Intravenous; Lymphoma, Mantle-Cell; Male; Middle Aged; Piperidines; Staurosporine

2002
Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes.
    Oncogene, 2004, Nov-25, Volume: 23, Issue:55

    Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Coloring Agents; Cyclophosphamide; DNA Damage; Enzyme Inhibitors; Flow Cytometry; Genes, p53; Humans; In Situ Hybridization, Fluorescence; Leukocytes, Mononuclear; Lymphoma, Mantle-Cell; Membrane Potentials; Mitochondria; Mitoxantrone; Proteins; Reactive Oxygen Species; Staurosporine; Time Factors; Translocation, Genetic; Tumor Suppressor Protein p53; Vidarabine

2004